Table 4. Comparison of the incidence rates of GBS in various countries.
| Study location | Data source | Diagnostic criteria | Period | Age (yr) | Cases | Incidence per 100,000 | Reference |
|---|---|---|---|---|---|---|---|
| Victoria, Australia | Medical record systems at teaching hospitals | Not reported | 1980–1984 | ≥15 | 110 | 0.90 | Storey et al.39 |
| Western Australia | Case record search for GBS, polyneuritis, or polyneuropathy codes | Asbury criteria | 1980–1985 | All | 109 | 1.35 | Hankey40 |
| UK | Population-based study using a general-practice research database | Codes for GBS or infective neuritis | 1992–2000 | All | 228 | 1.33 | Hughes et al.41 |
| Southeast England | A voluntary reporting scheme, hospital activity analysis, a contemporary research database, and death certificates | Asbury and Cornblath criteria | 1993 & 1994 | All | 79 | 1.20 | Rees et al.32 |
| Denmark | Danish national patient registry | ICD-8 code for polyradiculitis acuta and ICD-10 code for GBS | 1987–2016 | ≥16 | 2,319 | 1.77 | Levison et al.42 |
| Germany | Nationwide administrative database from reimbursement scheme implementation | ICD-10 code G61.0 | 2003–2005 | All | 4,349 | 1.60–1.89 | Lehmann et al.43 |
| Southwest Greece | Medical records at two referral hospitals | NINCDS | 1989–2001 | All | 105 | 0.99 | Chroni et al.29 |
| USA | Nationwide inpatient sample database | ICD-9-CM code for GBS (357.0) | 2000–2004 | ≥18 | 4,954 | 1.65–1.79 | Alshekhlee et al.36 |
| USA | Vaccine Safety Datalink | ICD-9 code for GBS (357.0) | 2000–2009 | All | 1,619 | 1.72 | Shui et al.16 |
| Finland | Hospital discharge database | Asbury criteria and Poser criteria | 1981–1986 | All | 247 | 0.84 | Kinnunen et al.44 |
| Finland | Finnish Care Register for Health Care | ICD-10 code G61.0 | 2004–2014 | All | 989 | 1.70 | Sipilä et al.45 |
| Italy | Italian network for the study of GBS | Asbury criteria | 2010 & 2011 | ≥18 | 365 | 1.84 | Benedetti et al.46 |
| Lombardy, Italy | Prospective hospital-based survey, in which patients were interviewed and atypical cases were discussed | NINCDS | 1994 & 1995 | All | 109 | 0.92 | Beghi et al.47 |
| Piemonte and Valle d’Aosta, Italy | Piemonte and Valle d’Aosta Register for Guillain-Barré Syndrome | ICD-9 codes 357.0, 357.8, and 357.9 | 1995 & 1996 | All | 120 | 1.36 | Chiò et al.48 |
| Taiwan | National Health Insurance Research Database | ICD-9-CM code for GBS (357.0) | 1997–2011 | All | 5,998 | 1.52–2.31 | Huang et al.18 |
| Jiangsu province, China | Survey | NINCDS | 2008–2010 | All | 441 | 0.59 | Chen et al.5 |
| Western Norway | Hospital records | NINCDS | 1957–1982 | All | 109 | 1.19 | Larsen et al.49 |
| Serbia | Medical records at five tertiary healthcare centers in Serbia | Brighton criteria | 2009–2018 | ≥18 | 640 | 1.07 | Stojanov et al.38 |
| Spain | Retrospective review of national health service | NINCDS | 1985–1997 | >19 | 337 | 0.86 | Cuadrado et al.50 |
| Sweden | Hospital Inpatient Register of the National Board of Health and Welfare in Sweden | ICD-9 code for GBS (357A) | 1978–1993 | All | 2,257 | 1.77 | Jiang et al.28 |
| Quebec and Ontario, Canada | Hospital discharge databases | ICD-9 codes 357.0, 357.8, 357.9, and 375.0 | 1983–1989 | All | 2,333 | 1.51–1.78 | McLean et al.51 |
| Chile | Department of Statistics and Health Information of the Chilean Ministry of Health for all public and private health providers in Chile | ICD-10 code for GBS (G61.0) | 2001–2012 | All | 4,158 | 1.61–2.35 | Rivera-Lillo et al.6 |
| Korea | Medical records at 28 randomly selected hospitals | Brighton criteria | 2008–2010 | All | 245 | 0.63–0.87 | Kim et al.9 |
| Korea | Korean National Health Insurance Service claims data | Hospitalized cases with ICD-10 code for GBS (G61.0) | 2014–2016 | ≥65 | 320 | 4.14–4.16 | Lee et al.8 |
GBS, Guillain-Barré syndrome; ICD, International Classification of Diseases; NINCDS, National Institute of Neurological and Communicative Disorders and Stroke Criteria.